Moving beyond immunoglobulin therapy for CIDP with efgartigimod

Bunschoten, C., Jacobs, B. C., Van den Bergh, P. Y. K., Cornblath, D. R. & van Doorn, P. A. Progress in diagnosis and treatment of chronic inflammatory demyelinating polyradiculoneuropathy. Lancet Neurol. 18, 784–794 (2019).

Article  CAS  PubMed  Google Scholar 

Lünemann, J. D. Getting specific: targeting Fc receptors in myasthenia gravis. Nat. Rev. Neurol. 17, 597–598 (2021).

Article  PubMed  Google Scholar 

Allen, J. A. et al. Safety, tolerability, and efficacy of subcutaneous efgartigimod in patients with chronic inflammatory demyelinating polyradiculoneuropathy (ADHERE): a multicentre, randomised-withdrawal, double-blind, placebo-controlled, phase 2 trial. Lancet Neurol. 23, 1013–1024 (2024).

Article  CAS  PubMed  Google Scholar 

Hansen, R. J. & Balthasar, J. P. Intravenous immunoglobulin mediates an increase in anti-platelet antibody clearance via the FcRn receptor. Thromb. Haemost. 88, 898–899 (2002).

Article  CAS  PubMed  Google Scholar 

Lünemann, J. D., Nimmerjahn, F. & Dalakas, M. C. Intravenous immunoglobulin in neurology—mode of action and clinical efficacy. Nat. Rev. Neurol. 11, 80–89 (2015).

Article  PubMed  Google Scholar 

Tackenberg, B. et al. Impaired inhibitory Fcγ receptor IIB expression on B cells in chronic inflammatory demyelinating polyneuropathy. Proc. Natl Acad. Sci. USA 106, 4788–4792 (2009).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Anthony, R. M., Kobayashi, T., Wermeling, F. & Ravetch, J. V. Intravenous gammaglobulin suppresses inflammation through a novel TH2 pathway. Nature 475, 110–113 (2011).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Quast, I., Cueni, F., Nimmerjahn, F., Tackenberg, B. & Lünemann, J. D. Deregulated Fcγ receptor expression in patients with CIDP. Neurol. Neuroimmunol. Neuroinflamm. 2, e148 (2015).

Article  PubMed  PubMed Central  Google Scholar 

Nelke, C., Spatola, M., Schroeter, C. B., Wiendl, H. & Lünemann, J. D. Neonatal Fc receptor-targeted therapies in neurology. Neurotherapeutics 19, 729–740 (2022).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Querol, L. A. et al. The role of the complement system in chronic inflammatory demyelinating polyneuropathy: implications for complement-targeted therapies. Neurotherapeutics 19, 864–873 (2022).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Comments (0)

No login
gif